A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer - Concepedia

Concepedia

Publication | Open Access

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

DOI Full Paper Access

85

Citations

25

References

2020

Year

Michael Kolinsky, Pasquale Rescigno, Diletta Bianchini, Zafeiris Zafeiriou, Niven Mehra, Joaquı́n Mateo, Vasiliki Michalarea, Ruth Riisnaes, Mateus Crespo, I. Figueiredo,

Annals of Oncology

References

	Year	Citations

Page 1